Revvity has grown revenue 0.87% a year over three years and −7.3% a year over five, with earnings per share compounding at −31%. Revenue growth, 3-year annual rate: +0.87% (Diagnostics & Research median +9.1%). Revenue growth, 5-year rate: −7.3%, growth has picked up over the last three years. Earnings per share, 3-year rate: −31%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 18, FY2008 to FY2025, as filed.

RVTYRevvity

HealthcareUSD

$126.37

$82.2652 weeks$126.37

Is it growing?

Is RVTY growing?

Revvity has grown revenue 0.87% a year over three years and −7.3% a year over five, with earnings per share compounding at −31%.

+0.87%

Revenue growth, 3-year annual rate · Diagnostics & Research median +9.1% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −7.3%
Revenue growth, 5-year rate · +0.87% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: −31%
Earnings per share, 3-year rate · revenue +0.87% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 18
Years of annual history on file · FY2008 to FY2025, as filed